Connect with us

Press Releases

Winpro Pet Closes on $3M+ in Funding

The investment comes from Next Level Ventures.

mm

Published

on

(PRESS RELEASE) WINPRO has closed on an investment from Next Level Ventures LLC, a venture capital firm located in Des Moines, IA. Proceeds from the raise will be immediately employed in funding company growth through marketing and new product development. Next Level Ventures joins long-time WINPRO partner Summit Equity Group as a key stakeholder in WINPRO.

“WINPRO was looking to take the next step and Next Level Ventures brings both needed capital and business expertise,” said WINPRO founder Bill Bernardo. “I’m especially excited about our future growth prospects especially as they relate to new products for dogs and possibly other species too.”

The investment was a Series B round of more than $3 million.

WINPRO, founded in 2016, brought to the dog world the science behind animal blood proteins which first came to light in the 1980s, when it was shown to reduce the mortality rate in weaning piglets. The science behind this discovery next crossed over to cattle and horses, until it was finally introduced by WINPRO to the canine health market. Today – as great news for any dog owner – the science is being put to work to extend the health and longevity for dogs of all breeds and sizes.

WINPRO is made in the USA. The company is based in Ankeny, IA, and all WINPRO products are manufactured by Majesty’s Animal Nutrition in Oregon. “Our partners are a key part of our success,” said Bernardo, “Our blood protein partner APC, Inc. is also Iowa based and they bring talent and know-how that makes our team and our products better”.

WINPRO President Tim Mitchum, who joined WINPRO in 2017, said, “There’s never been a more exciting time to be in the pet health industry. With the continued support of our amazing partners, we are now positioned to bring WINPRO PET’s truly unique and innovative products to more dogs around the world.”

Advertisement

Advertisement

FEATURED VIDEO

Sponsored by Cogent Solutions Group

Reduce Your Pet’s Hip & Joint Discomfort with the Most Researched Hyaluronan on the Market

Nearly 60% of dogs and 90% of cats suffer from joint discomfort. Trixsyn joint supplement contains a patented and proven hyaluronic acid molecule for maximum efficacy to promote joint, bone, soft tissue, and cartilage health, keeping your pet feeling comfortable, for longer. Trixsyn is veterinarian recommended, safe and all-natural, and contains research-proven ingredients. Get your paws on the most-researched hyaluronic acid on the market. Learn more at Trixsyn.com.

Promoted Headlines

Most Popular